Discodermolide: Past, present, and future

Natural Products and Cancer Drug Discovery

Volumn , Issue , 2013, Pages 39-58

  Longley, Ross E ^a  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85009673345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4654-5_3     Document Type: Chapter

References (76)

1. Arefolov A, Panek JS (2005) Crotylsilane reagents in the synthesis of complex polyketide natural products: total synthesis of (+)-discodermolide. J Am Chem Soc 127:5596-5603.
2. Bewley CA, Holland ND, Faulkner DJ (1996) Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbionts. Experientia 52:716-722.
3. Bröker LE, Huisman C, Ferreira CG, Rodriguez JA, Kruyt FAE, Giaccone G (2002) Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells. Cancer Res 62:4081-4088.
4. Bröker LE, Huisman C, Span SW, Rodriguez JA, Kruyt FE, Giaccone G (2004) Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64:27-30.
5. Brück WM, Sennett SH, Pomponi SA, Willenz P, McCarthy PJ (2008) Identification of the bacterial symbiont Entotheonella sp. in the mesohyl of the marine sponge Discodermia sp. ISME J 3:335-339.
6. Canales A, Matesanz R, Gardner NM, Andru JM, Paterson I, Diaz JF, Jiménez-Barbero J (2008) The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin. Chem Eur J 14:7557-7569.
7. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 98:15155-15160.
8. Davidson SK, Allen SW, Lim GE, Anderson CM, Haygood MG (2001) Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina. Appl Environ Microbiol 67:4531-4537.
9. de Lemos E, Poree FH, Commercon A, Betzer JF, Pancrazi A, Ardisson J (2007) Alpha-oxygenated crotyltitanium and dyotropic rearrangement in the total synthesis of discodermolide. Angew Chem Int Ed Engl 46:1917-1921.
10. Fan Y, Schreiber M, Day BW (2009) Human liver microsomal metabolism of (+)-discodermolide. J Nat Prod 72:1748-1754.
11. Florence GJ, Gardner NM, Paterson I (2008) Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. Nat Prod Rep 25:342-375.
12. Gunasekera SP, Gunasekera M, Longley RE (1990) Discodermolide, a new bioactive polyhydroxylated lactone from the marine sponge, Discodermia dissoluta. J Org Chem 55:4912-4915.
13. Gunasekera SP, Longley RE, Isbrucker RA (2001) Acetylated analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity. J Nat Prod 64:171-174.
14. Gunasekera SP, Longley RE, Isbrucker RA (2002a) Semisynthetic analogues of the microtubulestabilizing agent discodermolide: preparation and biological activity. J Nat Prod 65:1830-1837.
15. Gunasekera SP, Paul GK, Longley RE, Isbrucker RA, Pomponi SA (2002b) Five new discodermolide analogues from the marine sponge Discodermia species. J Nat Prod 65:1643-1648.
16. Harried SS, Lee CP, Yang G, Lee TI, Myles DC (2003) Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide. J Org Chem 22(68):6646-6660.
17. Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA (2004) Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res 64:4957-4964.
18. Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I (2006a) Targeting FtsZ for anti-tuberculosis drug discovery: non-cytotoxic taxanes as novel anti-tuberculosis agents. J Med Chem 49:463-466.
19. Huang GS, Barcons-Lope L, Freeze SB, Smith AB III, Goldberg GL, Horwitz SB, McDaid HM (2006b) Potentiation of taxol efficacy by discodermolide in ovarian carcinoma xenograft-bearing mice. Clin Cancer Res 12(1):298-304.
20. Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FAE, Giaccone G (2002) Paclitaxel triggers cell death primarily via caspase-independent routes in the nonsmall cell lung cancer cell line NCI-H460. Clin Cancer Res 8:596-606.
21. Hung DT, Nerenberg JB, Schreiber SL (1994) Distinct binding and cellular properties of synthetic (+) and (-) discodermolides. Chem Biol 1:67-71.
22. Hung DT, Chen J, Schreiber SL (1996a) (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest. Chem Biol 3:287-293.
23. Hung DT, Nerenberg JB, Schreiber SL (1996b) Syntheses of discodermolides useful for investigating microtubule binding and stabilization. J Am Chem Soc 118:11054-11080.
24. Isbrucker RA, Gunasekera SP, Longley RE (2001) Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity. Cancer Chemother Pharmacol 48:29-36.
25. Isbrucker RA, Cummins J, Pomponi SA, Longley RE, Wright AE (2003) Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin. Biochem Pharmacol 66:75-82.
26. Jogalekar AS, Kriel FH, Shi Q, Cornett B, Cicero D, Snyder JP (2010) The discodermolide hairpin structure flows from conformationally stable modular motifs. J Med Chem 53:155-165.
27. Khrapunovich-Baine M, Menon V, Verdier-Pinard P, Smith AB III, Angeletti RH, Fiser A, Horwitz SB, Xiao H (2009) Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization. Biochemistry 48:11664-11677.
28. Kinder FR Jr, Bair KW, Chen W, Florence, G, Francavilla C, Geng P, Gunasekera S, Guo Q, Lassota PT, Longley RE, Palermo MG, Paterson I, Pomponi S, Ramsey TM, Rogers L, Sabio M, Sereinig N, Sorensen E, Wang RM, Wright A (2002) Synthesis and antitumor activity of analogues of the novel microtubule stabilizing agent discodermolide. Abstracts of papers American Chemical Society, 224th ACS national meeting, Boston, MA, MEDI-236.
29. Klein LE, Freeze BS, Smith AB III, Horwitz SB (2005) The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. Cell Cycle 4:501-507.
30. Kowalski RJ, ter Haar E, Longley RE, Gunasekera SP, Lin CM, Day BW, Hamel E (1995) Comparison of novel microtubule polymerizing agents, discodermolide and epothilone A/B, with taxol. Mol Biol Cell 6:368a.
31. Kowalski RJ, Giannakakou P, Gunasekera SP, Longley RE, Day BW (1997) The microtubule stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel and inhibits the growth of paclitaxel-resistant cells. Mol Pharmacol 52:613-622.
32. Longley RE, Caddigan D, Harmody D, Gunasekera M, Gunasekera SP (1991a) Discodermolide-a new, marine-derived immunosuppressive compound. I. In vitro studies. Transplantation 52:650-656.
33. Longley RE, Caddigan D, Harmody D, Gunasekera M, Gunasekera SP (1991b) Discodermolide-a new, marine-derived immunosuppressive compound. II. In vivo studies. Transplantation 52:656-661.
34. Longley RE, Gunasekera SP, Faherty D, Mclane J, Dumont F (1993) Immunosuppression by discodermolide. Ann N Y Acad Sci 696:94-107.
35. Marshall JA, Johns BA (1998) Total synthesis of (+)-discodermolide. J Org Chem 63:7885-7892.
36. Martello LA, McDaid HM, Regl DL, Yang CH, Meng D, Pettus TRR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB, Horwitz SB (2000) Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res 6:1978-1987.
37. Martello LA, LaMarche MJ, He L, Beauchamp TJ, Smith AB, Horwitz SB (2001) The relationship between taxol and (+)-discodermolide: synthetic analogs and modeling studies. Chem Biol 8:843-855.
38. Mickel SJ, Sedelmeier GH, Niederer D, Daeffler R, Osmani A, Schreiner K, Seeger-Weibel M, Berod B, Schaer K, Gamboni R (2004a) Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 1: synthetic strategy and preparation of a common precursor. Org Process Res Dev 8:92-100.
39. Mickel SJ, Sedelmeier GH, Niederer D, Schuerch F, Grimler D, Koch G, Daeffler R, Osmani A, Hirni A, Schaer K, Gamboni R (2004b) Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 2: synthesis of fragment C1-6 and C9-14. Org Process Res Dev 8:101-106.
40. Mickel SJ, Sedelmeier GH, Niederer D, Schuerch F, Koch G, Kuesters E, Daeffler R, Osmani A, Seeger-Weibel S, Schmid E, Hirni A, Schaer K, Gamboni R (2004c) Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 3: synthesis of fragment C15-21. Org Process Res Dev 8:107-112.
41. Mickel SJ, Sedelmeier GH, Niederer D, Schuerch F, Seger M, Schreiner K, Daeffler R, Osmani A, Bixel D, Loiseleur O, Cercus J, Stettler H, Schaer K, Gamboni R (2004d) Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 4: preparation of fragment C7-24. Org Process Res Dev 8:113-121.
42. Mickel SJ, Niederer D, Daeffler R, Osmani A, Kuesters E, Schmid E, Schaer K, Gamboni R (2004e) Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 5: linkage of fragments C1-6 and C7-24 and finale. Org Process Res Dev 8:122-130.
43. Mita A, Lockhart AC, Chen TL, Bochinski K, Curtright J, Cooper W, Hammond L, Rothenberg M, Rowinsky E, Sharma S (2004) A phase I pharmacokinetic (PK) trial of XAA296A (discodermolide) administered every 3 wks to adult patients with advanced solid malignancies. J Clin Oncol 22:2025.
44. Myles DC (2003) Novel biologically active natural and unnatural products. Curr Opin Biotechnol 14:627-633.
45. Nerenberg JB, Hung DT, Somers PK, Schreiber SL (1993) Total synthesis of the immunosuppressive agent (-)-discodermolide. J Am Chem Soc 115:12621-12622.
46. O'Neil GW, Philips AJ (2006) Total synthesis of (-)-dictyostatin. J Am Chem Soc 128: 5340-5341.
47. Palmero MG, Bair W, Chen W, Guo Q, Lassota PT, Sorrensen E, Wang RM, Kinder FR Jr.(2002) Abstracts of papers, 224th meeting of the American Chemical Society. American Chemical Society, Boston, MA, Abstract ORGN 791.
48. Paterson I, Gardner NM (2007) Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid. Chem Commun 1:49-51.
49. Paterson I, Lyothier I (2004) Total synthesis of (+)-discodermolide: an improved endgame exploiting a Still-Gennari-type olefination with a C1-C8 C-ketophosphonate fragment. Org Lett 6:4933-4936.
50. Paterson I, Lyothier I (2005) Development of a third-generation total synthesis of (+)-discodermolide: an expedient Still-Gennari-type fragment coupling utilizing an advanced a-ketophosphonate. J Org Chem 70:5494-5507.
51. Paterson I, Florence GJ, Gerlach K, Scott JP (2000) Total synthesis of the antimicrotubule agent (+)-discodermolide using boron-mediated aldol reactions of chiral ketones. Angew Chem Int Ed Engl 39:377-380.
52. Paterson I, Delgado O, Florence GJ, Lyothier I, Scott JP, Sereinig N (2003) 1,6-Asymmetric induction in boron-mediated aldol reactions: application to a practical total synthesis of (+)-discodermolide. Org Lett 5:35-38.
53. Paterson I, Britton R, Delgado O, Meyer A, Poullennec KG (2004) Total synthesis and configurational assignment of (-)-dictyostatin, a microtubule-stabilizing macrolide of marine sponge origin. Angew Chem Int Ed Engl 43:4629-4633.
54. Paterson I, Naylor G, Wright AE (2008) Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide. Chem Commun 38:4628-4630.
55. Paterson I, Naylor GJ, Fujita T, Guzmán E, Wright AE (2010) Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin. Chem Commun 46:261-263.
56. Sanchez-Pedregal VS, Kubicek K, Meiler J, Lyothier I, Paterson I, Carlomagno T (2006) The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide. Angew Chem Int Ed Engl 45:7388-7394.
57. Shaw SJ (2008) The structure activity relationship of discodermolide analogues. Mini Rev Med Chem 8:276-284.
58. Shaw SJ, Sundermann KF, Burlingame MA, Myles DC, Freeze BS, Xian M, Brouard I, Smith AB III (2005) Toward understanding how the lactone moiety of discodermolide affects activity. J Am Chem Soc 127:6532-6533.
59. Shaw SJ, Sundermann KF, Burlingame MA, Shang D, Petryka J, Myles DC (2006) A series of 23,24-dihydrodiscodermolide analogues with simplified lactone regions. Bioorg Med Chem Lett 16:1961-1964.
60. Shin Y, Choy N, Turner TR, Balachandran R, Madiraju C, Day BW, Curran DP (2002) Discodermolide/dictyostatin hybrids: synthesis and biological evaluation. Org Lett 4:4443-4446.
61. Shin Y, Fournier J-H, Fukui Y, Brückner AM, Curran DP (2004) Total synthesis of dictyostatin 1 provides its relative and absolute configuration. Angew Chem Int Ed Engl 43:4634-4637.
62. Shin Y, Fournier J-H, Bruckner A, Madiraju C, Balachandran R, Raccor BS, Edler MC, Hamel E, Sikorski RP, Vogt A, Day BW, Curran DP (2007) Synthesis and biological evaluation of (-)-dictyostatin and stereoisomers. Tetrahedron 63:8537-8562.
63. Shirmer A, Gadkari R, Reeves CD, Ibrahim F, DeLonge EF, Hutchinson CR (2005) Metagenomic analysis reveals diverse polyketide synthase gene clusters in microorganisms associated with the marine sponge Discodermia dissoluta. Appl Environ Microbiol 71:4840-4849.
64. Smith AB III, Qiu YP, Jones DR, Kobayashi K (1995) Total synthesis of (-)-discodermolide. J Am Chem Soc 117:12011-12012.
65. Smith AB III, Kaufman MD, Beaucham TJ, LaMarche MJ, Arimoto H (1999) Gram-scale synthesis of (+)-discodermolide. Org Lett 1:1823-1826.
66. Smith AB, Beauchamp TJ, LaMarche MJ, Kaufman MD, Qiu Y, Arimoto H, Jones DR, Kobayashi K (2000) Evolution of gram-scale synthesis of (+) discodermolide. J Am Chem Soc 122:8654-8664.
67. Smith AB, LaMarche M, Falcone-Hindley M (2001) Solution structure of (+)-discodermolide. Org Lett 3:695-698.
68. Smith AB, Freeze BS, Brouard I, Hirose T (2003) A practical improvement, enhancing the largescale synthesis of (+)-discodermolide: a third-generation approach. Org Lett 5:4405-4408.
69. Smith AB III, Freeze BS, Lamarche MJ, Hirose T, Brouard I, Rucker PV, Xian M, Sundermann KF, Shaw SJ, Burlingame MA, Horwitz SB, Myles DC (2005a) Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide. Org Lett 7:311-314.
70. Smith AB III, Freeze BS, LaMarche MJ, Hirose T, Brouard I, Xian M, Sundermann KF, Shaw SJ, Burlingame MA, Horwitz SB, Myles DC (2005b) Design, synthesis, and evaluation of analogues of (+)-14-normethyldiscodermolide. Org Lett 7:315-318.
71. Smith AB III, Freeze BS, Xian M, Hirose T (2005c) Total synthesis of (+)-discodermolide: a highly convergent fourth-generation approach. Org Lett 7:1825-1828.
72. Smith AB III, Freeze BS, LaMarche MJ, Sager J, Kinzler KW, Vogelstein B (2005d) Discodermolide analogues as the chemical component of combination bacteriolytic therapy. Bioorg Med Chem Lett 15:3623-3626.
73. Smith AB III, Rucker PV, Brouard I, Freeze BS, Xia S, Horwitz SB (2005e) Design, synthesis, and biological evaluation of potent discodermolide fluorescent and photoaffinity molecular probes. Org Lett 7:5199-5202.
74. Sundermann KF, Shaw SJ, Burlingame MA, Myles DC, Freeze SB, Xian M, Brouard J, Smith AB III (2005) Abstracts of papers, 229th meeting of the American Chemical Society. American Chemical Society, San Diego, CA, Abstract MEDI 417.
75. ter Haar E, Kowalski RJ, Hamel E, Lin CM, Longley RE, Gunasekera SP, Rosenkranz HS, Day BW (1996) Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 35:243-250.
76. Unson MD, Faulkner DJ (1993) Cyanobacterial symbiont biosynthesis of chlorinated metabolites from Dysidea herbacea (Porifera). Experientia 49:349-353.